『COX / 5-LOX dual inhibitor anti-inflammatory analgesic


‘Monimate tablet’ launched』

 


KyungDong Pharm Co., Ltd. launched the COX/5-LOX dual inhibitor anti-inflammatory analgesic ‘Monimate Tablet (Moniflumate 350mg)’ in September 2010.

Monimate tablets are not only effective in treating inflammation and respiratory diseases, but are also a product that reduces cardiovascular risks that may be caused by selective COX-2 inhibitors.

When administered in combination with antibiotics, faster antipyretic action, reduced coughing frequency, difficulty in sputum discharge, and chest pain can be expected compared to antibiotic administration alone, and gastrointestinal side effects can be reduced by increasing gastroprotective prostaglandin.

Additionally, the dosage for this product is simple to take twice a day, and up to 1,400 mg can be administered per day.

Monimate Tablets can be used for a wide range of respiratory, ear, nose, throat, bone and joint conditions. Sales in the antipyretic and analgesic market are expected to grow as colds and arthritis become more prevalent during seasonal changes.


《Product Information》

 

▷ Ingredient content: Morniflumate 350mg
|
▷ Efficacy: Pain relief and anti-inflammatory for the following diseases and symptoms
1. Respiratory diseases (laryngitis, tracheitis, bronchitis)
2. ENT diseases (sinusitis, otitis, tonsillitis, pharyngitis)
3. Bone and joint disease

▷ Dosage: Adults - Take 350 mg twice a day, once as the initial dose.
Depending on the patient, up to 700 mg per dose may be taken twice daily.

▷ Appearance: White to light yellow, oblong tablet

▷ Insurance drug price: 227 won / fixed

▷ Packaging unit: 30 tablets / 100 tablets (BTL)

▷ Insurance code: 648102910

* For further details, please refer to the product manual.